Navigation Links
Increase Cereal Fibre To Combat Atherosclerosis

New research findings elevate the role of fibres further by stating that cereal fibre and whole-grain products may slow atherosclerosis and plaque build-up in the arteries in postmenopausal women.//

Previous studies linked dietary fibre, particularly cereal fibre, with a decreased risk of heart disease and death. Investigating the effect of dietary fibres from cereal, whole-grains, fruit, and vegetables, and refined grain products on the progression of existing coronary artery disease in women was the aim of this study.

229 postmenopausal women with 30 percent artery blockage participating in the Oestrogen Replacement and Atherosclerosis trial were chosen as the target study group. The food frequency questionnaire was used to estimate the dietary fibre. The coronary arteries were assessed for the change in mean coronary artery diameter and mean percent stenosis or artery narrowing over a period of three years.

The researchers found that compared to those who had lower intakes, those with more than three grams of cereal fibre or six servings of whole grains per week were associated with a smaller decline in minimum coronary artery diameter after considering other factors including age, cardiovascular risk factors and dietary intakes of saturated and polyunsaturated fat, cholesterol, and alcohol.

Slower progression of stenosis was also observed in those with high intakes of cereal fibre or whole grain products. The effect of grain fibre or whole grains on stenosis is almost the same as that observed in patients treated with cholesterol-lowering statin drugs.

No association between intakes of total, fruit, and vegetable fibre and the number of servings of refined grain, fruits or vegetables with artery narrowing progression.

Overall, the results indicated that high intakes of cereal fibre or whole grain products may reduce the risk of atherosclerosis in postmenopausal women.
'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Increase in sugar...decrease in brain function!!!
3. Increase in tobacco deaths
4. Increased Heart Attack Risk From Celebrex,Vioxx
5. Deep Sleep Doesnt Increase Memory
6. Allergy Risk Increased by Kerosene Use
7. IVF technique May Increase The Risk Of Birth Defects
8. Step Aerobics Increases good cholesterol
9. Increase in renal problems
10. Fewer teeth & Increased Ischemic Stroke risk
11. Painkillers Increase Risk of Miscarriage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... 2017 , ... “The Majestic Unicorn”: a poignant book that describes what ... the creation of published author, Dayna Chantel, an artist and a writer. , Chantel ... march aboard the cypress ark-vessel. Male and female, no matter what species, they were ...
(Date:9/25/2017)... ... , ... The trend-spotters, tastemakers, and healthy lifestyle product experts at the ... drinks, with the new NEXTY Gold Award at the Natural Products Expo East trade ... which is reserved for just those companies that hit high marks on the criteria ...
(Date:9/25/2017)... Church, VA (PRWEB) , ... September 25, 2017 ... ... Handling and Response Preconference Workshop, **Presented by FDAnews**, Nov. 1-3, 2017 – Bethesda, ... the drugmaker passed with flying colors. And then, on the tenth inspection it ...
(Date:9/25/2017)... CA (PRWEB) , ... September 25, 2017 , ... ... music video on Thursday, September 28, 2017 to deliver a powerful message of ... On film Franchise. , Feature film writer/director Robert Adetuyi (Beat the World, Stomp ...
(Date:9/24/2017)... ... September 25, 2017 , ... Andrea Purcell, NMD, had an epiphany one evening. Four months ... her dinner plate. She thought pregnancy was so hard. She wondered why no one talks ... than her. In that moment, she decided to write what she wished her friends and ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical stage ... Ideation and Behavior (ASIB), has been granted Fast Track status ... therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + ... pivotal trial of this sequential therapy targeting patients who are ... ...
(Date:9/5/2017)...  Xyntek Inc. has announced another milestone in their continued growth and success ... the growing demands of customer engagements regionally.  ... new Midwest office is located at 318 West Adams Street, Suite 1528, Chicago, ... Xyntek's recently opened ... ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: